Peptide compounds derived from a shifted ORF of the iCE gene
US6875844B1 · kind B1 · utility
8Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 27, 2000 |
| Grant date | Apr 5, 2005 |
| Priority date | — |
| Expiry date | Jun 27, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/021
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a peptide compound which causes a tumor-specific T response, and which comprises a sequence of at least 8 consecutive amino acids of the peptide sequence encoded by a frame-shifted sequence of the iCE gene. The invention also relates to a pharmaceutical composition comprising said peptide compound and to the use of these compounds for manufacturing a medicinal product intended for treating cancer, in particular for treating solid tumors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.